Impact of Self-Monitoring of Blood Glucose with a Monthly Group Discussion on Glycemic Control in Diabetic Subjects
Main Article Content
Abstract
Good glycemic control is important to reduce diabetic complications. We investigated an impact of self-monitoring of blood glucose (SMBG) on glycemic control from 54 diabetic subjects whose HbA1c>8% in the Endocrine Clinic, Maharat Nakhon Ratchasima Hospital. All had participated in the diabetic educational program and were advised to do SMBG twice daily. Thirty-three subjects attended in the monthly group discussion (age 57±2y, DM duration 11±2y), and 21 subjects (age 56±3y, DM duration 12±2y) did not. For subjects who attended in the monthly group discussion, 3 decided to discontinue SMBG, 3 lost follow-up, and 27 continued the program. After three months, HbA1c levels decreased in all subjects when compared with their baseline levels (mean HbA1c 10.2±.3% to 7.6±.2%, p<0.001).Almost half of them had HbA1c<7%. Subjects who did SMBG without attending in the monthly group discussion, 80% of them had lower Hba1c levels after three months compared to their baseline(HbA1c 9.9±0.3% to 83±0.3%, p<0.001). Fourteen percents of subjects had Hba1c <7%. Comparing between both groups, Mean difference of HbA1c between baseline and after three months from subjects who attended in the monthly group discussion was higher than those from subjects without attending in the group discussion (2.7±0.3% vs 1.6±0.4%, p= 0.037). No severe hypoglycemia was reported. In conclusions, SMBG had a positive effect on glycemic control. A monthly group discussion with healthcare professionals enhanced the benefit of SMBG. (Poster presentation for the 15th Congress of the ASEAN Federation of Endocrine Societies. November 29-December 1,2009, Bangkok, Thailand)
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes melitus. N Eng J Med 1993; 329: 977-86.
Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-12.
การตรวจระดับน้ำตาลในเลือดด้วยตนเอง. แนวทางเวชปฏิบัติสำหรับโรคเบาหวาน พ.ศ. 2554 พิมพ์ครั้งที่ 2. หน้า 35-38.
American Diabetes Association: Standard of medical care in diabetes. Diabetes Care 2011; 34: S11-S61.
International Diabetes Federation. Guideline: Self monitoring of blood glucose in non-insulin treated type 2 diabetes 2008.
Davidson MB, Castellanos M, Kain D, Duran P. The efficacy of self-monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005; 118: 422-5.
Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomized trial. BMJ 2007; 335: 132-7.
O'Kane MJ, Bunting B, Copeland M, Coates VE,ESMON study group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomized controlled trial. BMJ 2008;336:1147-7.
Kempf K, Neukirchen W, Martin S, Kolb H. Self-moni-toring of blood glucose in type 2 diabetes: a new look at published trials. Diabetologia 2008; 51:686-8.